Deborah DiSanzo and Christine Douglass of IBM Watson Health with JSK
Deborah DiSanzo and Christine Douglass of IBM Watson Health with JSK
By Jane Sarasohn-Kahn on 2 February 2018 in
I was interviewed live on BNN Bloomberg (Canada) on the market for GLP-1 drugs for weight loss and their impact on both the health care system and consumer goods and services -- notably, food, nutrition, retail health, gyms, and other sectors.
Looking forward to speaking at OSF Healthcare's first digital summit to highlight the growing movement of healthcare-to-home, empowering and supporting patients for self-care, and bolstering community health citizen-by-citizen, clinician-by-clinician.
I had a wide-ranging conversation with WCBU reporter Collin Schopp to discuss the role of telehealth in health care to expand access, equity, quality, clinician well-being and patient engagement. We spoke in advance of my keynote speech to be delivered at the inaugural OSF Digital Health Symposium on October 16, 2024, in Peoria, IL.